Neural implants combining artificial intelligence with microelectronics could directly modulate the brain’s activity to help treat brain disorders, including Parkinson’s disease. “Neurons talk to each other in part via electrical signals, and a therapeutic neural implant produces electrical stimulation – like a pacemaker for the brain. In cases of…
New York University Langone Health is collaborating with the Michael J. Fox Foundation for Parkinson’s Research in the Parkinson’s Progression Markers Initiative, a research program aiming to contribute to disease diagnosis and treatment. Launched in 2010 by the Michael J. Fox Foundation and a group of academic researchers…
A research team at the Icahn School of Medicine at Mount Sinai, New York has won the 2022 Parkinson’s Foundation Research Center Award, valued at $2 million, to study the process that results in the selective loss of dopaminergic neurons in Parkinson’s disease. The team, led by…
CENTOGENE has announced it’s reached a milestone of 12,500 participants who have been recruited and genetically tested as part of the Rockstock International Parkinson’s Disease Study (ROPAD), a global observational effort to characterize the genetic profile of Parkinson’s patients. ROPAD (NCT03866603), developed in collaboration with Denali…
Older age at onset, more severe motor symptoms, and cognitive impairment are risk factors for the progression of gait and postural instability in Parkinson’s disease patients who undergo deep brain stimulation, a new study suggests. Researchers, who followed patients for up to 15 years after the surgery, found…
Free art therapy workshops for Parkinson’s disease patients and their caregivers will take place this fall in Little Rock and Hot Springs, Arkansas, offered by the University of Arkansas for Medical Sciences (UAMS) Movement Disorders Clinic. The Art for Parkinson’s classes are scheduled in Little Rock at St. Michael’s…
Poor sleep quality is a key factor in developing dyskinesia, the uncontrolled and involuntary movements that can affect people with Parkinson’s disease, a study that followed patients for up to three years suggests. “[Poor sleep quality] may increase the risk of developing dyskinesia in PD [Parkinson’s disease], implying that therapeutic…
Researchers have devised a new method to generate dopamine-producing neurons from skin cells of Parkinson’s disease patients, a process that could be used to better study the molecular mechanisms of the disease and develop new treatments. The cells retained many relevant aspects of the disease, including the accumulation of…
Servier is set to launch a Phase 1 clinical trial in healthy volunteers to investigate an LRRK2 inhibitor, developed in collaboration with Oncodesign, as a treatment for Parkinson’s disease. The trial, to start before the end of the year, follows the clearance of the Phase 1 clinical trial…
Older age at onset, a faster rate of disease progression, and severe cognitive impairment are key factors in poorer survival rates for people with Parkinson’s disease, a study that followed patients in northern China for 10 years found. Fatigue may also be an indicator of poorer survival, while physical exercise…
Visit the Parkinson’s News Today forums to connect with others in the Parkinson’s community.
Get regular updates to your inbox.